z-logo
open-access-imgOpen Access
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Author(s) -
Roland Schmitz,
George W. Wright,
Da Wei Huang,
Calvin A. Johnson,
James D. Phelan,
James Q. Wang,
Sandrine Roulland,
Monica Kasbekar,
Ryan M. Young,
Arthur L. Shaffer,
Daniel J. Hodson,
Wenming Xiao,
Xin Yu,
Yandan Yang,
Hong Zhao,
Weihong Xu,
Xuelu Liu,
Bin Zhou,
Wei Du,
Wing C. Chan,
Elaine S. Jaffe,
Randy D. Gascoyne,
Joseph M. Connors,
Elı́as Campo,
Armando LópezGuillermo,
Andreas Rosenwald,
German Ott,
Jan Delabie,
Lisa M. Rimsza,
Kevin Tay Kuang Wei,
Andrew D. Zelenetz,
John P. Leonard,
Nancy L. Bartlett,
Bao Tran,
Jyoti Shetty,
Yongmei Zhao,
Dan Soppet,
Stefania Pittaluga,
Wyndham H. Wilson,
Louis M. Staudt
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1801445
Subject(s) - biology , germinal center , diffuse large b cell lymphoma , lymphoma , cell of origin , gene expression profiling , genetics , gene , pathogenesis , b cell , cancer research , gene expression , immunology , antibody
Diffuse large B-cell lymphomas (DLBCLs) are phenotypically and genetically heterogeneous. Gene-expression profiling has identified subgroups of DLBCL (activated B-cell-like [ABC], germinal-center B-cell-like [GCB], and unclassified) according to cell of origin that are associated with a differential response to chemotherapy and targeted agents. We sought to extend these findings by identifying genetic subtypes of DLBCL based on shared genomic abnormalities and to uncover therapeutic vulnerabilities based on tumor genetics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom